|
|
||||||||
Brain Imaging Center, Montreal Neurological Institute and Hospital, and the Department of Neurology and Neurosurgery of McGill University
Correspondence: For reprints contact: Jane L. Tyler, MD, Brain Imaging Center, Montreal Neurology Institute and Hospital, 3801 University, Montreal, Quebec, Canada H3A 2B4.
ABSTRACT
The pharmacokinetics of i.v. and superselective intra-arterial carbon-11 1,3-bis-(2-chloroethyl)-1-nitrosourea ([11C]BCNU) were directly compared for the first time in ten patients with recurrent gliomas using positron emission tomography (PET). Intra-arterial administration of [11C]BCNU achieved concentrations of the drug in the tumor that averaged 50 times higher than with a comparable i.v. dose. These preliminary results suggest that the degree of early metabolic trapping of BCNU in tumor correlates with the clinical response to this chemotherapy.
This article has been cited by other articles:
![]() |
D. S. Boss, R. V. Olmos, M. Sinaasappel, J. H. Beijnen, and J. H. M. Schellens Application of PET/CT in the Development of Novel Anticancer Drugs Oncologist, January 1, 2008; 13(1): 25 - 38. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. P. Gobin, T. F. Cloughesy, K. L. Chow, G. R. Duckwiler, J. W. Sayre, K. Milanese, and F. Viñuela Intraarterial Chemotherapy for Brain Tumors by Using a Spatial Dose Fractionation Algorithm and Pulsatile Delivery Radiology, March 1, 2001; 218(3): 724 - 732. [Abstract] [Full Text] |
||||
![]() |
R O Robinson, C D Ferrie, M Capra, and M N Maisey Positron emission tomography and the central nervous system Arch. Dis. Child., September 1, 1999; 81(3): 263 - 270. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |